Closed System Drug Transfer Device (CSTD) Market to Reach $3.6 Billion, Globally, by 2033 at 15.7% CAGR: Allied Market Research
10. Oktober 2024 10:29 ET
|
Allied Analytics LLP
Wilmington, Delaware, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Closed System Drug Transfer Device (CSTD) Market by Type (Membrane to membrane and...
Oncology/Cancer Drugs Market to Reach $335.2 Billion, Globally, by 2033 at 7.2% CAGR: Allied Market Research
01. August 2024 21:30 ET
|
Allied Analytics LLP
Wilmington, Delaware, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Oncology/Cancer Drugs Market by Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy...
Ovarian Cancer Drugs Market Size Worth USD 5.35 Billion in 2032 | Emergen Research
28. November 2023 11:00 ET
|
Emergen Research
Vancouver, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The global ovarian cancer drugs market is set to experience substantial expansion, reaching a size of USD 2.40 Billion in 2022 and projecting an...
IRBM Selected for Participation in National Chemical Biology Consortium
04. April 2023 03:00 ET
|
IRBM
ROME, April 04, 2023 (GLOBE NEWSWIRE) -- IRBM, a drug discovery and early development research institute and global contract research organization, announces that it is joining the Chemical Biology...
Processa Pharmaceuticals to Host Conference Call to Discuss 2022 Year End Results and Provide Drug Development Update on March 30, 2023 at 4:30 p.m. EST
23. März 2023 08:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, March 23, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a developer of Next Generation Chemotherapy drugs that provide a better...
Oncology Cancer Drugs Market Size is projected to reach USD 288 Billion by 2030, growing at a CAGR of 7.7%: Straits Research
15. August 2022 15:50 ET
|
Straits Research
New York, United States, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Cancer develops when the body's common control mechanism malfunctions and cannot stop the proliferation of abnormal cells. In this case,...
RAFA To Add Major Component to the Tashkent Pharma Park
17. Dezember 2021 11:34 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and the Czech company “Block” signed an agreement on the implementation of the construction of a...
Cancer and Allied Advancements in Chemotherapy – Straits Research
16. September 2021 09:00 ET
|
Straits Research
New York, US, Sept. 16, 2021 (GLOBE NEWSWIRE) -- The chemotherapy market is expected to grow at a compound annual growth rate (CAGR) of 10.4% in the forecast period from 2020 to 2029. The global...
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs
19. August 2021 10:25 ET
|
RAFARMA PHARMACEUTICALS INC
Nicosia, Cyprus, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) and one of the world's largest producers of precious metals, Krastsvetmet (Russia, Krasnoyarsk), discussed...
Oncology/Cancer Drugs Market to Reach $222.38 Bn by 2027 at 7.4% CAGR
20. April 2021 08:40 ET
|
Allied Market Research
Portland, OR, April 20, 2021 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Oncology/Cancer Drugs Market by Drug Class Type (Chemotherapy, Targeted Therapy, Immunotherapy,...